In a world where nostalgia reigns supreme, the millennial aesthetic is experiencing a surprising yet unmistakable revival.
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of ...